Filter

Refine by collections

  • Hormones and Cancer (16)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 16 items for :

  • hormone therapy x
  • Hormones and Cancer x
Clear All
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

predominately on symptom severity at presentation is not helpful in guiding decisions about hormone replacement and continuation or discontinuation of ICPI therapy for endocrinopathies ( 2 ). Immune-related endocrinopathies do not fit into a five-tier symptoms

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0513
Volume/Issue:
Volume 12: Issue 5
Open access
Enrique Pedernera Universidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Embriología y Genética, Ciudad de México, México

Search for other papers by Enrique Pedernera in
Google Scholar
PubMed Close
,
Flavia Morales-Vásquez Instituto Nacional de Cancerología, Ciudad de México, México

Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed Close
,
María J Gómora Universidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Embriología y Genética, Ciudad de México, México

Search for other papers by María J Gómora in
Google Scholar
PubMed Close
,
Miguel A Almaraz Universidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Embriología y Genética, Ciudad de México, México

Search for other papers by Miguel A Almaraz in
Google Scholar
PubMed Close
,
Esteban Mena Universidad Nacional Autónoma de México, Facultad de Medicina, Secretaría General, Ciudad de México, México
Universidad La Salle, Posgrado de la Facultad de Ciencias Químicas, Ciudad de México, México

Search for other papers by Esteban Mena in
Google Scholar
PubMed Close
,
Delia Pérez-Montiel Instituto Nacional de Cancerología, Ciudad de México, México

Search for other papers by Delia Pérez-Montiel in
Google Scholar
PubMed Close
,
Elizabeth Rendon Hospital Militar de Especialidades de la Mujer y Neonatología. Ciudad de México, México

Search for other papers by Elizabeth Rendon in
Google Scholar
PubMed Close
,
Horacio López-Basave Instituto Nacional de Cancerología, Ciudad de México, México

Search for other papers by Horacio López-Basave in
Google Scholar
PubMed Close
,
Juan Maldonado-Cubas Universidad La Salle, Posgrado de la Facultad de Ciencias Químicas, Ciudad de México, México

Search for other papers by Juan Maldonado-Cubas in
Google Scholar
PubMed Close
, and
Carmen Méndez Universidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Embriología y Genética, Ciudad de México, México

Search for other papers by Carmen Méndez in
Google Scholar
PubMed Close

in tumor cell proliferation after E2 treatment ( 28 ). Moreover, hormone replacement therapy in menopausal women is recognized as a risk factor for ovarian cancer ( 29 ); consequently, tumor progression associated with the presence of E2 might be

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0315
Volume/Issue:
Volume 12: Issue 12
Open access
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed Close
,
Johan Botling Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Search for other papers by Johan Botling in
Google Scholar
PubMed Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed Close
,
Barbro Eriksson Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Barbro Eriksson in
Google Scholar
PubMed Close
,
Staffan Welin Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Staffan Welin in
Google Scholar
PubMed Close
,
Anders Sundin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Anders Sundin in
Google Scholar
PubMed Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed Close

demonstrated longer survival for panNET-G3 (range, 41–42 months) than for panNEC (range, 9–17 months) ( 8 , 9 ). Moreover, it has been hypothesized that panNET-G3 and panNEC respond differently to systemic therapy, with higher response rates on platinum

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0604
Volume/Issue:
Volume 11: Issue 3
Open access
Margarida Brito Department of Medical Oncology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Margarida Brito in
Google Scholar
PubMed Close
,
Susana Prazeres Department of Clinical Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Susana Prazeres in
Google Scholar
PubMed Close
, and
Marta Malheiros Department of Clinical Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Marta Malheiros in
Google Scholar
PubMed Close

/6 inhibitors and also in monotherapy. In premenopausal patients, fulvestrant requires the combination with a gonadotropin‐releasing hormone (GnRH) agonist therapy for ovarian suppression (OS) ( 6 ). However, studies show that 17–24% ( 7 , 8 ) of

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0178
Volume/Issue:
Volume 12: Issue 11
Open access
Orwa Dandash Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Orwa Dandash in
Google Scholar
PubMed Close
,
James Allebone Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by James Allebone in
Google Scholar
PubMed Close
,
Adam Mirabelli Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Adam Mirabelli in
Google Scholar
PubMed Close
,
Nicholas Russell Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Nicholas Russell in
Google Scholar
PubMed Close
,
Mathis Grossmann Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close
,
Andrea Gogos Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia

Search for other papers by Andrea Gogos in
Google Scholar
PubMed Close
, and
Richard A Kanaan Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Richard A Kanaan in
Google Scholar
PubMed Close

Introduction Androgen deprivation therapy (ADT) using gonadotropin-releasing hormone (GnRH) agonists is one of the mainstay therapies for prostate cancer ( 1 ). This therapy reduces circulating testosterone to castrate concentrations

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0409
Volume/Issue:
Volume 13: Issue 3
Open access
Josephina G Kuiper PHARMO Institute for Drug Outcomes Research, AE Utrecht, Netherlands
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands

Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed Close
,
Aline C Fenneman Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Aline C Fenneman in
Google Scholar
PubMed Close
,
Anne H van der Spek Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Anne H van der Spek in
Google Scholar
PubMed Close
,
Elena Rampanelli Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Elena Rampanelli in
Google Scholar
PubMed Close
,
Max Nieuwdorp Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed Close
,
Myrthe P P van Herk-Sukel Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands

Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed Close
,
Valery E P P Lemmens Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands

Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed Close
,
Ernst J Kuipers Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands

Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed Close
,
Ron M C Herings PHARMO Institute for Drug Outcomes Research, AE Utrecht, Netherlands
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands

Search for other papers by Ron M C Herings in
Google Scholar
PubMed Close
, and
Eric Fliers Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Eric Fliers in
Google Scholar
PubMed Close

.nivel.nl/nl/nivel-zorgregistraties-eerste-lijn/jaarcijfers-aandoeningen-incidenties-en-prevalenties ). Treatment of primary hypothyroidism consists of hormone substitution therapy with daily oral administration of the synthetic thyroid hormone levothyroxine. The majority of levothyroxine is absorbed in the upper gastrointestinal tract, ranging from 40 to 80

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0463
Volume/Issue:
Volume 11: Issue 1
Open access
Hanna Karhapää Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Karhapää in
Google Scholar
PubMed Close
,
Siru Mäkelä Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Siru Mäkelä in
Google Scholar
PubMed Close
,
Hanna Laurén Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Laurén in
Google Scholar
PubMed Close
,
Marjut Jaakkola Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Marjut Jaakkola in
Google Scholar
PubMed Close
,
Camilla Schalin-Jäntti Medical Faculty, University of Helsinki, Helsinki, Finland
Endocrinology, Abdominal Centre, University of Helsinki and HUS, Helsinki, Finland

Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed Close
, and
Micaela Hernberg Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Micaela Hernberg in
Google Scholar
PubMed Close

permanent hormone deficiencies requiring lifelong substitution therapies, but on the other hand, endocrine AEs seem to be related to longer PFS and OS. Based on our results, a systematic laboratory and patient follow-up are highly recommendable during ICI

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0562
Volume/Issue:
Volume 11: Issue 2
Open access
Daniel Alexander Hescheler Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany

Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed Close
,
Milan Janis Michael Hartmann Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany

Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed Close
,
Burkhard Riemann Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Search for other papers by Burkhard Riemann in
Google Scholar
PubMed Close
,
Maximilian Michel Institute of Zoology, University of Cologne Germany, Cologne, Germany

Search for other papers by Maximilian Michel in
Google Scholar
PubMed Close
,
Christiane Josephine Bruns Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany

Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed Close
,
Hakan Alakus Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany

Search for other papers by Hakan Alakus in
Google Scholar
PubMed Close
, and
Costanza Chiapponi Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Cologne, Cologne, Germany

Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed Close

time of diagnosis ( 1 ) which generally requires a systemic therapy in addition to surgery and/or radiation therapy. A recent single-institution retrospective study on 479 patients treated at the University of Texas MD Anderson Cancer Center over 20

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0624
Volume/Issue:
Volume 11: Issue 4
Open access
Vita Birzniece School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia

Search for other papers by Vita Birzniece in
Google Scholar
PubMed Close
,
Teresa Lam School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia

Search for other papers by Teresa Lam in
Google Scholar
PubMed Close
,
Mark McLean School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Mark McLean in
Google Scholar
PubMed Close
,
Navneeta Reddy Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Navneeta Reddy in
Google Scholar
PubMed Close
,
Haleh Shahidipour School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed Close
,
Amy Hayden School of Medicine, Western Sydney University, New South Wales, Australia
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia

Search for other papers by Amy Hayden in
Google Scholar
PubMed Close
,
Howard Gurney Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia

Search for other papers by Howard Gurney in
Google Scholar
PubMed Close
,
Glenn Stone School of Computing, Engineering and Mathematics, Western Sydney University, New South Wales, Australia

Search for other papers by Glenn Stone in
Google Scholar
PubMed Close
,
Rikke Hjortebjerg Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark

Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed Close
, and
Jan Frystyk Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark

Search for other papers by Jan Frystyk in
Google Scholar
PubMed Close

radiation therapy for high-risk prostate cancer. Exclusion criteria were visceral metastases, castrate-resistant prostate cancer (PSA progression defined as at least 3 PSA rises, measured on three successive occasions ≥ 1 week apart after hormonal

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0375
Volume/Issue:
Volume 11: Issue 4
Open access
Xiaoya Zheng Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed Close
,
Shanshan Yu Pathology Department, Chongqing Medical University, Chongqing, China

Search for other papers by Shanshan Yu in
Google Scholar
PubMed Close
,
Jian Long Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Jian Long in
Google Scholar
PubMed Close
,
Qiang Wei Prevention of Disease Department, Chongqing Jiulongpo District Hospital of Traditional Chinese Medicine, Chongqing, China

Search for other papers by Qiang Wei in
Google Scholar
PubMed Close
,
Liping Liu Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Liping Liu in
Google Scholar
PubMed Close
,
Chun Liu Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Chun Liu in
Google Scholar
PubMed Close
, and
Wei Ren Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Wei Ren in
Google Scholar
PubMed Close

triiodothyronine, thyroxine, free triiodothyronine (FT3), free thyroxine (FT4), ultrasensitive thyroid-stimulating hormone (uTSH), thyroid peroxidase antibody (TPOAb), thyroid antithyroglobulin autoantibody (TgAb) and parathyroid hormone were detected by an

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0364
Volume/Issue:
Volume 11: Issue 1
Open access